56 results
8-K
EX-10.1
ELTX
Elicio Therapeutics, Inc.
12 Aug 24
Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note
4:24pm
, hearing, enforcement, investigation, arbitration or other action from the FDA or any other Governmental Entity or third party alleging that any product … or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has not received notice
8-K
EX-1.1
ELTX
Elicio Therapeutics, Inc.
28 Jun 24
Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering
7:08pm
of Sale Prospectus and the Prospectus; and (iii) have not received notice of any actual or potential liability for the investigation or remediation … violation of any term of any such Authorizations; (D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation
S-8
xii3xnl8muik
29 Mar 24
Registration of securities for employees
3:28pm
8-K
EX-10.1
hqb4jq9y 7j
18 Mar 24
Entry into a Material Definitive Agreement
8:05am
8-K
EX-10.1
ei1abx4 cr12v
22 Dec 23
Entry into a Material Definitive Agreement
9:06am
S-8
9d3gm
21 Aug 23
Registration of securities for employees
5:30pm
8-K
EX-99.3
sjvvb
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
pt86xgzqj7s 59
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-10.8
zr18qxqii5q1hm
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
bn7q05pkl0 ejv
28 Apr 23
Prospectus supplement
4:07pm